Lexicon Pharmaceuticals (LXRX) Reports Q1 EPS Loss of $0.09
Lexicon Pharmaceuticals (NASDAQ: LXRX) reported Q1 EPS ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
